- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CAREMAX Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 347,00 | +1,36 % | Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition? | ||
| UNITEDHEALTH | 327,00 | -0,37 % | Dividendenbekanntmachungen (14.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BROOKFIELD CORPORATION CA11271J1075 0,07 USD 0,0603 EUR BROOKFIELD WEALTH SOLUTIONS LTD BMG174341047 0,07 USD 0,0603 EUR CALAMOS... ► Artikel lesen | |
| THERMO FISHER | 573,00 | +1,06 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | +5,10 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CENTENE | 57,04 | +0,64 % | Biotech Stocks At 52-Week Highs - Nutex Health +8%, Iovance Biotherapeutics +7%, AtriCure, Centene, Concentra Group | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 15, 2026, driven by the gain on certain clinical or financial results.Nutex Health Inc. (NUTX)Nutex Health... ► Artikel lesen | |
| QUIDELORTHO | 9,076 | -1,99 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,480 | +3,55 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,806 | -16,44 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| NANO-X IMAGING | 0,728 | -2,39 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| FULGENT GENETICS | 18,900 | 0,00 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| LANTHEUS | 87,60 | 0,00 % | Lantheus Holdings, Inc.: Lantheus Announces FDA Approval of TAUKLARIFY (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer's Disease | BEDFORD, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,610 | +4,99 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck & Co., Inc. to Evaluate [212Pb]PSV359 in Combination with Keytruda (Pembrolizumab) in FAP-a Positive Solid Tumors | SEATTLE, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| OMNICELL | 28,000 | -0,71 % | TraceLink, Inc.: TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations | Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 29,400 | +2,08 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Second Quarter 2026 Results | Quarterly revenue of $673 million and adjusted EBITDA of $73 million;
GAAP income of $0.53/share and adjusted EPS of $0.77
DALLAS, Aug. 6, 2026 /PRNewswire/ --... ► Artikel lesen |
CAREMAX INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREMAX INC finden Sie auf Wallstreet Online.